Novartis Investigative Site

Shenyang 110004

2 studies enrolling now · 2 studies all time

What they study most

Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Post-essential Thrombocythemia Myelofibrosis (PET-MF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Primary Myelofibrosis (PMF)

Studies at this site

• A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) — Recruiting now
• Asciminib Roll-over Study — Recruiting now